Breast Ultrasound
General imaging

Breast ultrasound

A universal platform for breast ultrasound

Breast cancer is the second most common cancer diagnosed in women, accounting for more than one in 10 new cancer diagnoses each year. Deaths from breast cancer have declined over time, but breast cancer remains the second leading cause of cancer death among women overall.1 In women with dense breast tissue, small lesions can be masked, making them harder to detect and potentially delaying diagnosis.

Demonstrated results in Breast Ultrasound

  1. 85%

    More efficient crystals

    85%

    More efficient crystals

    The uniform crystals of PureWave are 85% more efficient than traditional piezoelectric (PZT) material in converting electrical input into acoustic output 4

  2. 2x

    The sensitivity and resolution of MFI

    2x

    The sensitivity and resolution of MFI

    MicroFlow Imaging (MFI HD) offers 2x the sensitivity and resolution of MFI in assessing blood flow 3

  3. 54%

    reduction in number of button pushes

    54%

    reduction in number of button pushes

    NextGeneration AutoSCAN reduces button pushes by up to 54% with pixel-by-pixel real time optimization 5

Assess, monitor and treat breast disease

When mammography indicates a need for further testing, our portfolio of breast ultrasound imaging solutions is up to the task. Philips offers a single transducer ultrasound solution with four key features that work together to effectively assess, monitor and treat breast diseases, including PureWave, elastography, Anatomical Intelligence and precision biopsy capabilities. This combination of excellent image quality with clinical tools aids physicians in efficient diagnosis and patient care.

Image quality, advanced insights, workflow and support

  • Image quality:  Elevate diagnostic confidence, see pathology with high resolution and perform biopsies with fewer passes.5
  • Advanced insights:  Improve productivity and reproducibility and rapidly determine tissue stiffness to assess a wide array of breast pathology.6
  • Workflow:  Benefit from an efficient and intuitive experience with outstanding ease of use, improved image uniformity, and a reduced need for repeat scans.5
  • A trusted partner:  Experience a partner who offers support that is tailored to your needs and teams.

Advanced tools for breast ultrasound

  • The eL18-4 and mL26-8 transducers provide excellent B-mode imaging, needle visualization that enhances the needle tip, strain and shear wave elastography and MicroFlow imaging.
  • MicroFlow Imaging HD detects small vessel blood flow with twice the sensitivity and resolution of MicroFlow.3
  • ElastQ Imaging shear wave and strain elastography reveal more definitive information on tissue stiffness in the breast.
  • Precision biopsy capabilities reduce needle blind zones and enhance the display of needle reflections.
  • Flow Viewer defines vasculature with a 3D-like appearance with reduced flash artifact.

Image gallery

  • Superficial Cyst with Calcifications
    Superficial Cyst with Calcifications
  • Breast Flow Viewer
    Flow Viewer represents vascular flow topography with a 3D-like appearance and MicroFlow Imaging is designed to detect and assess blood flow anatomy in tissue.
  • Breast Mass
    As demonstrated with the eL18-4 Transducer, Strain Elastography is a non-invasive, real-time imaging technique that displays an overlay of stiffness information over a greyscale 2D image.
  • eL18-4 with 2D Imaging
    eL 18-4 transducer with 2D imaging
  • EPIQ Elite Elevate with L26-8 probe for Breast with Superficial Cyst
    EPIQ Elite Elevate with L26-8 probe for Breast with Superficial Cyst

The addition of elastography to every breast ultrasound has now produced a positive biopsy rate in excess of 80% vecayse fewer viopsies that are later found to be unnecessary are performed.

Richard G. Barr
FACR, FSRU, FAIUM
Ultrasound Web Barr Testimonial Breast

Documentation

shear wave elastography for breast
PDF|(2.89 MB)
Footnotes
  1. Breast Cancer Statistics. U.S. Centers for Disease Control and Prevention (CDC). September 16, 2024.
  2. As seen in, A comprehensive solution using the Philips eL18-4 PureWave linear transducer, 2018.
  3. Internal measured comparison on standards MFI to MFI HD using clinical targets and standard measurement methodology. Not available on Affiniti systems.
  4. When comparing release 10 performance to release 7 performance.
  5. As seen in, Breakthrough ultrasound solutions for breast imaging in clinical practice, December 2018.
  6. Introducing next-generation shear wave elastography for breast (Philips ElastQ), July 2018.
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.